These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22219226)

  • 1. Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study.
    Campos M; Buchanan A; Yu F; Barbalic M; Xiao Y; Chambless LE; Wu KK; Folsom AR; Boerwinkle E; Dong JF
    Blood; 2012 Feb; 119(8):1929-34. PubMed ID: 22219226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects.
    Song J; Chen F; Campos M; Bolgiano D; Houck K; Chambless LE; Wu KK; Folsom AR; Couper D; Boerwinkle E; Dong JF
    PLoS One; 2015; 10(8):e0132626. PubMed ID: 26244499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans.
    Tang W; Cushman M; Green D; Rich SS; Lange LA; Yang Q; Tracy RP; Tofler GH; Basu S; Wilson JG; Keating BJ; Weng LC; Taylor HA; Jacobs DR; Delaney JA; Palmer CD; Young T; Pankow JS; O'Donnell CJ; Smith NL; Reiner AP; Folsom AR
    Am J Hematol; 2015 Jun; 90(6):534-40. PubMed ID: 25779970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible race and gender divergence in association of genetic variations with plasma von Willebrand factor: a study of ARIC and 1000 genome cohorts.
    Zhou Z; Yu F; Buchanan A; Fu Y; Campos M; Wu KK; Chambless LE; Folsom AR; Boerwinkle E; Dong JF
    PLoS One; 2014; 9(1):e84810. PubMed ID: 24465435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Single Nucleotide Polymorphisms in the ST3GAL4 Gene with VWF Antigen and Factor VIII Activity.
    Song J; Xue C; Preisser JS; Cramer DW; Houck KL; Liu G; Folsom AR; Couper D; Yu F; Dong JF
    PLoS One; 2016; 11(9):e0160757. PubMed ID: 27584569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms and mutations in vWF and ADAMTS13 genes and their correlation with plasma levels of FVIII and vWF in patients with deep venous thrombosis.
    Bittar LF; de Paula EV; Mello TB; Siqueira LH; Orsi FL; Annichino-Bizzacchi JM
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):514-8. PubMed ID: 20682599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci.
    De Visser MC; Sandkuijl LA; Lensen RP; Vos HL; Rosendaal FR; Bertina RM
    J Thromb Haemost; 2003 Aug; 1(8):1771-6. PubMed ID: 12911592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project.
    Johnsen JM; Auer PL; Morrison AC; Jiao S; Wei P; Haessler J; Fox K; McGee SR; Smith JD; Carlson CS; Smith N; Boerwinkle E; Kooperberg C; Nickerson DA; Rich SS; Green D; Peters U; Cushman M; Reiner AP;
    Blood; 2013 Jul; 122(4):590-7. PubMed ID: 23690449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation factor VIII: Relationship to cardiovascular disease risk and whole genome sequence and epigenome-wide analysis in African Americans.
    Raffield LM; Lu AT; Szeto MD; Little A; Grinde KE; Shaw J; Auer PL; Cushman M; Horvath S; Irvin MR; Lange EM; Lange LA; Nickerson DA; Thornton TA; Wilson JG; Wheeler MM; ; Zakai NA; Reiner AP
    J Thromb Haemost; 2020 Jun; 18(6):1335-1347. PubMed ID: 31985870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.
    Albánez S; Ogiwara K; Michels A; Hopman W; Grabell J; James P; Lillicrap D
    J Thromb Haemost; 2016 May; 14(5):953-63. PubMed ID: 26875505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.
    Biguzzi E; Castelli F; Lijfering WM; Cannegieter SC; Eikenboom J; Rosendaal FR; van Hylckama Vlieg A
    Thromb Res; 2021 Jan; 197():172-178. PubMed ID: 33221577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels.
    de Vries PS; Reventun P; Brown MR; Heath AS; Huffman JE; Le NQ; Bebo A; Brody JA; Temprano-Sagrera G; Raffield LM; Ozel AB; Thibord F; Jain D; Lewis JP; Rodriguez BAT; Pankratz N; Taylor KD; Polasek O; Chen MH; Yanek LR; Carrasquilla GD; Marioni RE; Kleber ME; Trégouët DA; Yao J; Li-Gao R; Joshi PK; Trompet S; Martinez-Perez A; Ghanbari M; Howard TE; Reiner AP; Arvanitis M; Ryan KA; Bartz TM; Rudan I; Faraday N; Linneberg A; Ekunwe L; Davies G; Delgado GE; Suchon P; Guo X; Rosendaal FR; Klaric L; Noordam R; van Rooij F; Curran JE; Wheeler MM; Osburn WO; O'Connell JR; Boerwinkle E; Beswick A; Psaty BM; Kolcic I; Souto JC; Becker LC; Hansen T; Doyle MF; Harris SE; Moissl AP; Deleuze JF; Rich SS; van Hylckama Vlieg A; Campbell H; Stott DJ; Soria JM; de Maat MPM; Almasy L; Brody LC; Auer PL; Mitchell BD; Ben-Shlomo Y; Fornage M; Hayward C; Mathias RA; Kilpeläinen TO; Lange LA; Cox SR; März W; Morange PE; Rotter JI; Mook-Kanamori DO; Wilson JF; van der Harst P; Jukema JW; Ikram MA; Blangero J; Kooperberg C; Desch KC; Johnson AD; Sabater-Lleal M; Lowenstein CJ; Smith NL; Morrison AC
    Blood; 2024 May; 143(18):1845-1855. PubMed ID: 38320121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium.
    Smith NL; Chen MH; Dehghan A; Strachan DP; Basu S; Soranzo N; Hayward C; Rudan I; Sabater-Lleal M; Bis JC; de Maat MP; Rumley A; Kong X; Yang Q; Williams FM; Vitart V; Campbell H; Mälarstig A; Wiggins KL; Van Duijn CM; McArdle WL; Pankow JS; Johnson AD; Silveira A; McKnight B; Uitterlinden AG; ; Aleksic N; Meigs JB; Peters A; Koenig W; Cushman M; Kathiresan S; Rotter JI; Bovill EG; Hofman A; Boerwinkle E; Tofler GH; Peden JF; Psaty BM; Leebeek F; Folsom AR; Larson MG; Spector TD; Wright AF; Wilson JF; Hamsten A; Lumley T; Witteman JC; Tang W; O'Donnell CJ
    Circulation; 2010 Mar; 121(12):1382-92. PubMed ID: 20231535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort.
    Campos M; Sun W; Yu F; Barbalic M; Tang W; Chambless LE; Wu KK; Ballantyne C; Folsom AR; Boerwinkle E; Dong JF
    Blood; 2011 May; 117(19):5224-30. PubMed ID: 21343614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease.
    Kroner PA; Friedman KD; Fahs SA; Scott JP; Montgomery RR
    J Biol Chem; 1991 Oct; 266(29):19146-9. PubMed ID: 1918030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study.
    Conlan MG; Folsom AR; Finch A; Davis CE; Sorlie P; Marcucci G; Wu KK
    Thromb Haemost; 1993 Sep; 70(3):380-5. PubMed ID: 8259533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications.
    Casonato A; Pontara E; Zerbinati P; Zucchetto A; Girolami A
    Am J Clin Pathol; 1998 Mar; 109(3):347-52. PubMed ID: 9495210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels.
    Antoni G; Oudot-Mellakh T; Dimitromanolakis A; Germain M; Cohen W; Wells P; Lathrop M; Gagnon F; Morange PE; Tregouet DA
    BMC Med Genet; 2011 Aug; 12():102. PubMed ID: 21810271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort.
    Borràs N; Garcia-Martínez I; Batlle J; Pérez-Rodríguez A; Parra R; Altisent C; López-Fernández MF; Costa Pinto J; Batlle-López F; Cid AR; Bonanad S; Cabrera N; Moret A; Mingot-Castellano ME; Navarro N; Pérez-Montes R; Marcellini S; Moreto A; Herrero S; Soto I; Fernández-Mosteirín N; Jiménez-Yuste V; Alonso N; de Andrés-Jacob A; Fontanes E; Campos R; Paloma MJ; Bermejo N; Berrueco R; Mateo J; Arribalzaga K; Marco P; Palomo Á; Castro Quismondo N; Iñigo B; Del Mar Nieto M; Vidal R; Martínez MP; Aguinaco R; Tenorio M; Ferreiro M; García-Frade J; Rodríguez-Huerta AM; Cuesta J; Rodríguez-González R; García-Candel F; Dobón M; Aguilar C; Corrales I; Vidal F
    Thromb Haemost; 2020 Mar; 120(3):437-448. PubMed ID: 32135566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor.
    Kroner PA; Foster PA; Fahs SA; Montgomery RR
    Blood; 1996 Feb; 87(3):1013-21. PubMed ID: 8562925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.